DREAMM-8
DREAMM-8: Phase III Trial of Belantamab Mafodotin + Pomalidomide/Dexamethasone (BPd) vs Pomalidomide + Bortezomib/Dexamethasone (PVd) in RRMM

Released: June 04, 2024

Expiration: June 03, 2025

Activity

Progress
1
Course Completed